Clinical Trial Update: Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of glucose-dependent insulinotropic polypeptide (GIP) on bone turnover markers in patients with Type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Glucose-dependent insulinotropic polypeptide (glucose-dependent insulinotropic polypeptide)

Snippet

Sponsor: Mikkel Christensen | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED